Carotid Artery Disease and Stroke Prevention

Carotid artery disease is atherosclerotic narrowing of the extracranial carotid arteries, most importantly at the carotid bifurcation. It matters chiefly because a stenotic, plaque-laden carotid can be a source of thromboembolism to the brain, making its detection and management a central question in the prevention of ischaemic stroke.

Definition

Carotid artery disease, in the vascular-surgical sense, denotes atherosclerotic stenosis of the extracranial carotid artery; when the plaque becomes a source of emboli or the stenosis is severe it raises the risk of transient ischaemic attack and ischaemic stroke, which is the basis for considering revascularization in addition to medical therapy.

Scope

This entry covers the pathophysiology of carotid stenosis, the distinction between symptomatic and asymptomatic disease, the embolic mechanism linking plaque to stroke, and the broad options for stroke prevention - medical therapy, carotid endarterectomy, and carotid stenting. It is a reference topic within vascular surgery fundamentals and does not provide individualized clinical recommendations.

Core questions

• How does carotid plaque cause ischaemic stroke?
• Why does the symptomatic-versus-asymptomatic distinction drive management?
• How do carotid endarterectomy and carotid artery stenting compare?
• What role does intensive medical therapy play in modern stroke prevention?

Key concepts

• Carotid bifurcation atherosclerosis
• Artery-to-artery thromboembolism
• Symptomatic versus asymptomatic stenosis
• Degree of stenosis
• Carotid endarterectomy
• Carotid artery stenting
• Stroke risk reduction

Mechanisms

Atherosclerotic plaque at the carotid bifurcation can narrow the lumen and, more importantly, become unstable and ulcerated, shedding platelet-fibrin and cholesterol emboli that travel distally and occlude intracranial arteries, producing transient ischaemic attacks or strokes; severe stenosis can also reduce cerebral perfusion. Because the risk depends on whether the lesion has already caused symptoms and on the degree of stenosis, these features stratify the expected benefit of removing or excluding the plaque. Carotid endarterectomy removes the plaque surgically, while carotid stenting reopens the artery and traps debris from within, and both are weighed against the periprocedural stroke risk and against intensive medical therapy (nascet-1991, brott-2010, kleindorfer-2021).

Clinical relevance

Carotid disease is a major modifiable contributor to ischaemic stroke, and the way symptomatic and asymptomatic high-grade stenosis are evaluated illustrates how procedural risk is balanced against stroke-prevention benefit. This entry presents those concepts for educational reference; decisions about screening, medical therapy, or revascularization for any individual rest on current guidelines and specialist assessment, not on this overview (kleindorfer-2021).

Epidemiology

Carotid stenosis shares the risk factors of systemic atherosclerosis - age, smoking, hypertension, diabetes, and dyslipidaemia - and accounts for a meaningful share of ischaemic strokes, particularly those due to large-artery atherosclerosis. Asymptomatic stenosis is more common than symptomatic disease, and its lower per-year stroke risk under modern medical therapy is part of why management of asymptomatic lesions remains actively studied (nascet-1991, kleindorfer-2021).

History

Carotid endarterectomy was developed in the mid-twentieth century and was placed on a firm evidence base by landmark randomised trials in the early 1990s, notably NASCET, which quantified the benefit of surgery in symptomatic high-grade stenosis. Subsequent trials such as CREST compared endarterectomy with carotid stenting, and improvements in medical therapy have continued to reshape the threshold for intervention, especially in asymptomatic disease (nascet-1991, brott-2010, rutherford-2018).

Debates

Management of asymptomatic carotid stenosis

As intensive medical therapy has lowered the stroke risk of asymptomatic stenosis, the incremental benefit of endarterectomy or stenting in these patients has become uncertain and is the subject of ongoing trials and debate.

Endarterectomy versus stenting

Randomised comparison shows the two procedures trade off different periprocedural risks - stenting carrying more periprocedural stroke and endarterectomy more myocardial infarction - so the preferred approach depends on patient age, anatomy, and risk profile.

Seminal works

• nascet-1991
• brott-2010
• kleindorfer-2021

Frequently asked questions

How does a narrowed carotid artery cause a stroke?

Most carotid-related strokes happen when an unstable plaque sheds emboli that lodge in the brain's arteries rather than because flow is simply reduced; very severe stenosis can also limit perfusion.

What is the difference between symptomatic and asymptomatic carotid stenosis?

Symptomatic stenosis has already caused a transient ischaemic attack or stroke on the corresponding side and carries a higher near-term stroke risk, whereas asymptomatic stenosis is found before any event; this distinction strongly influences how the disease is managed.